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Summary
We carried out a critical appraisal and synthesis of the systematic reviews and meta-analyses of remote monitoring for heart
failure. A comprehensive literature search identified 65 relevant publications from 3333 citations. Seventeen studies fulfilled the
inclusion and exclusion criteria. Seven (41%) systematic reviews pooled results for meta-analysis. Eight (47%) considered all
non-invasive remote monitoring strategies. Five (29%) focused on telemonitoring. Four (24%) included both non-invasive
and invasive technologies. The reviews were appraised by two independent reviewers for their quality and risk of bias using
the AMSTAR tool. According to the AMSTAR criteria, ten (58%) systematic reviews were of poor methodological quality. In the
high quality reviews, the relative risk of mortality in patients who received remote monitoring ranged from 0.53 to 0.88. The
high quality reviews also reported that remote monitoring reduced the relative risk of all-cause (0.52 to 0.96) and heart failure-
related hospitalizations (0.72 to 0.79) and, as a consequence, healthcare costs. However, further research is required before
considering widespread implementation of remote monitoring. The subset of the heart failure population that derives the most
benefit from intensive monitoring, the best technology, and the optimum duration of monitoring, all need to be identified.
Accepted: 24 July 2013
Introduction
The healthcare literature contains reports of hundreds of
thousands of interventional studies and is growing.1
Systematic reviews are performed to critically appraise
and synthesise data from individual studies that focus
on a speciﬁc clinical problem or question. In a systematic
review, the methods used to identify, select and critically
appraise relevant research and to collect and analyse data
from the individual studies identiﬁed are explicitly stated.2
To increase power, data collected from the individual stu-
dies included in a systematic review can be accumulated in
what is known as a meta-analysis.2 Clinical practice guide-
lines try to use the best available evidence to provide rec-
ommendations and a meta-analysis is accorded the highest
level of evidence. However, in areas that have attracted a
large amount of research, it is now common for there to
be numerous systematic reviews and meta-analyses.3,4
Therefore, there is also a need for critical appraisal and
synthesis of systematic reviews and meta-analyses in order
to ensure that decision-making is informed by the best
available accumulated evidence. The ‘meta-review’,
which is an overview of systematic reviews, can be used
for this purpose.2
The aim of a meta-review is to critically appraise
and synthesise ﬁndings from systematic reviews and
meta-analyses. This contrasts with a systematic review,
in which the intent is to critically appraise and synthesise
ﬁndings from individual studies. The methodological dif-
ference between a conventional systematic review, which
may or may not incorporate meta-analysis, and a meta-
review, is that the latter only considers results reported in
systematic reviews and meta-analyses, not results
from individual studies. However, meta-reviews
should utilise methods that are similar to a traditional
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systematic review. For example, in a meta-review, the
methods used to review the literature, conduct quality
assessment of included reviews and synthesise ﬁndings,
need to be explicitly stated.2
Early identiﬁcation of clinical deterioration in patients
with heart failure by remotely monitoring for signs and
symptoms of ﬂuid accumulation or measuring ﬂuid status
can help prevent hospitalization for acute decompensated
heart failure.5 Remote monitoring interventions for heart
failure can be categorized as either invasive or non-
invasive. Invasive interventions involve direct measure-
ment of physiological variables, such as heart rate and
pulmonary artery pressures, by an implanted device
which is then transmitted for the health care provider to
access. Non-invasive interventions include telemonitoring
and structured telephone support. Telemonitoring
involves the transmission of physiological data, such as
bodyweight, blood pressure and pulse oximetry, and
other data, such as self-care practices, for the health
care provider to access.6 Structured telephone support
involves direct contact between a health care provider
and the heart failure patient.6 Both invasive and non-inva-
sive remote monitoring interventions for heart failure
have been evaluated in numerous randomized controlled
trials (RCTs), systematic reviews and meta-analyses.
There is a need for critical appraisal and synthesis of the
systematic reviews and meta-analyses. We have therefore
conducted a meta-review.
Methods
We applied the principles of the Cochrane methodology to
the meta-review.2 We conducted a comprehensive litera-
ture search. The reviews identiﬁed were then analysed by
summarising and comparing the population, intervention,
comparison and outcomes that were reported. In addition,
a quality appraisal of each review was undertaken using a
validated tool.7
Search
The following databases were searched: CINAHL, the
Cochrane Database of Systematic Reviews, the JBI library
of systematic reviews, EMBASE, Health source nursing/
academic edition and MEDLINE. The database searches
were supplemented by manual searching of reference lists
and a forward citation search was performed using
Google Scholar. Only published reviews were considered.
Two reviewers investigated all data sources to maximize
the scope of the search, and to reduce errors and bias.
Publication limits of 1996 to 2012 (inclusive) were set
for all literature searches. Only articles written in full-
text English were included. All potentially relevant publi-
cations were retrieved in full-text for review purposes. The
search used boolean operators to combine free text terms
and/or MeSH terms including heart failure, cardiac
failure, telehealth, telephone, telemonitoring, impedance
cardiography, remote sensing technology and
disease-management. A full list of the search terms used
is shown in the Appendix (see ONLINE ARCHIVE).
Study selection
Titles and abstracts were screened to eliminate articles that
were clearly irrelevant. Potentially eligible publications
were retrieved and the full text version was reviewed in
detail. Two reviewers independently selected studies for
inclusion and a third reviewer was available for arbitration.
The inclusion and exclusion criteria are shown in Box 1.
Data extraction
In addition to extracting data about the characteristics of
the review, such as the number of studies included, year of
publication and the total number of participants, data
Box 1. Inclusion and exclusion criteria.
Inclusion criteria
Study type: Systematic review of original research. In accordance
with the PRISMA statement, a systematic review was defined as a
review with a clearly formulated question that used systematic and
explicit methods to identify, select and critically appraise relevant
research and to collect and analyse data from the studies that were
included in the review.6,35 The review had to describe a detailed
search of the literature for relevant studies and synthesis of results
Publication: Full peer-reviewed publication
Population: Adult patients with a definitive diagnosis of heart failure
and recently discharged from an acute care setting to home
(excluding nursing homes or convalescent homes) or recruited
while managed in the community setting
Intervention: Remote monitoring of patients with heart failure;
initiated by a healthcare professional; delivered as the only heart
failure disease management intervention, without home-visits or
intensified clinic follow-up; targeted towards the patient, and not
caregivers; did not include any visits at home by a specialized CHF
healthcare professional or study personnel for the purpose of edu-
cation or clinical
Comparison: Consisted of standard post-discharge care without
intensified attendance at cardiology clinics or clinic-based CHF dis-
ease management programme or home-visits
Outcomes: All-cause mortality, CHF-related or all-cause hospitaliza-
tions, length of stay, cost of the intervention or cost reductions,
quality of life, acceptability, and adherence
Exclusion criteria
Remote monitoring of conditions other than heart failure
Reviews could not include studies that involved home-visits by spe-
cialized CHF health professionals or study personnel for the pur-
pose of education or clinical assessment or include intensified clinic
follow-up
Studies were excluded if any face-to-face patient assessment was
conducted as part of the intervention
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about the population, intervention, comparison and out-
comes were extracted. These data were extracted with a
standardised tool by two reviewers, and checked by a
third reviewer when uncertainties were encountered.
Quality appraisal
Reviews were appraised by two independent reviewers for
their quality and risk of bias using the AMSTAR tool.
This is a measurement tool, with good content validity,
for the assessment of multiple systematic reviews.7 The
AMSTAR criteria also provided a standardised method
to determine the extent to which the scientiﬁc quality of
the studies was assessed in the systematic reviews. This
criterion is an important element in the preparation of a
Cochrane overview of reviews.2 Our deﬁnition of high-
quality was a review that addressed at least eight of the
11 AMSTAR criteria. We decided that setting a cut-oﬀ for
the total score to indicate quality would be appropriate, as
psychometric testing of the AMSTAR tool revealed that,
as each component of the score measures a diﬀerent
domain of quality, the summary score is meaningful.7
Data synthesis
As many of the systematic reviews included the same stu-
dies, it was not appropriate to pool results from the indi-
vidual meta-analyses.8
Results
Overall, 65 publications from 3333 citations were identi-
ﬁed as being potentially relevant. Seventeen fulﬁlled the
inclusion and exclusion criteria in Figure 1.
The average number of studies included in the reviews
was 19.5 (SD¼ 14; range¼ 5–56), see Table 1. Eight
reviews (47%) included only RCTs. A further eight
reviews (47%) included a range of experimental, quasi-
experimental and cohort designs, while one review also
included ﬁndings from qualitative studies.
Systematic review quality
The quality of the reviews varied considerably, with
AMSTAR scores of 2–11 (mean 5.9; SD¼ 2.8). Only the
two reviews performed according to the Cochrane
Collaboration method fulﬁlled all of the AMSTAR cri-
teria.9,10 Eight reviews (47%) did not assess the scientiﬁc
quality of the included studies and only three (43%) of the
systematic reviews that performed meta-analyses
accounted for publication bias.
Methods used to synthesise results
Seven of the systematic reviews (41%) pooled results from
individual studies for meta-analysis.9–15 Heterogeneity of
interventions was managed by the authors of one of the
Records identified through 
database searching
n = 3173
Additional records 
identified from forward 
citation search
n = 166 
Records after duplicates 
removed
n = 3167
Records screened
n = 3333
Records excluded
n = 3268
Full-text articles 
assessed for eligibility
n = 65
Reviews included 
in synthesis
n = 17
Full-text articles excluded, with reasons
Systematic search strategy not used n = 41
Not heart failure specific n = 1
Remote rehabilitation not monitoring n = 1
Included reviews n = 2
Technology not focused on remote monitoring n = 3
Figure 1. Search results.
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Cochrane reviews by pooling results of interventions
that were similar, namely telemonitoring and
structured telephone support, separately.10 In contrast,
the meta-analyses undertaken by Klersy et al.11,12 con-
sidered all remote monitoring interventions together,
including even invasive monitoring strategies, and used
random-eﬀects models to account for signiﬁcant statistical
heterogeneity.11,12
Most reviews that did not use meta-analysis used a
narrative approach to synthesise the ﬁndings (n¼ 8;
47%). The remainder (n¼ 2; 12%) interpreted results
based on the level of evidence produced according to the
type of study design that had been utilized (e.g.
RCT¼Level II evidence).16,17
Populations
The characteristics of the populations included in the
reviews are summarised in Table 2. Either the mean
(including SD) or range of ages of participants was
reported in all of the systematic reviews. The oldest
reported mean age in a study was 82 years18 and the
youngest was 45 years.10 Similarly, the New York Heart
Association (NYHA) class of participants was reported in
most reviews. The majority of reviews reported that par-
ticipants were NYHA class II-IV.
Other population characteristics of the studies included
in the systematic reviews were not reported consistently.
For example, sex distribution was summarized in only ﬁve
reviews,10–12,18,19 left ventricular ejection fraction (LVEF)
reported in four, patients’ medications reported in only
two reviews13,19 and a summary of comorbidities in only
one systematic review.13
A single review reported sub-group populations within
individual studies. Inglis et al.10 emphasized that studies
included in their systematic review provided evidence of
the eﬀectiveness of remote monitoring in Hispanic and in
older people with heart failure.
Interventions and technology
Eight reviews (47%) considered all non-invasive remote
monitoring strategies, including structured telephone sup-
port and automated telemonitoring.9,15,17,18,20,21 Five
reviews (29%) focused speciﬁcally on telemonitoring,
which involved automated physiological and/or symptom
monitoring.13,16,22–24 Four reviews (24%) included studies
investigating both non-invasive and invasive remote moni-
toring technologies.11,12,25,26 One review focused speciﬁc-
ally on remote monitoring performed by nurses.15 None of
the systematic reviews speciﬁcally focused on invasive
remote monitoring.
Outcomes
Outcomes that were reported in the systematic reviews are
summarized in Table 3. Death and hospitalizations were
most often reported. Four reviews focused on only one
speciﬁc outcome, including cost,24,27 patient satisfaction23
and self-care.21 It was also common for the reviews to
report on healthcare costs, compliance with monitoring
and patient satisfaction with, or acceptance of, the
intervention.
Mortality
Five meta-analyses identiﬁed signiﬁcant improvements in
all-cause mortality for remote monitoring compared with
usual care,9,10,12–14 see Figure 2. Relative risk ranged from
0.53 (95% CI¼ 0.29–0.96)12 to 0.88 (95% CI¼ 0.76–
1.01).10 The greatest beneﬁt was seen in a meta-analysis
of cohort studies, which included both non-invasive and
invasive remote monitoring.12 Two meta-analyses sug-
gested that the reduction in mortality with telemonitoring
was more pronounced compared with structured tele-
phone support.10,12 In the systematic reviews that did
not incorporate meta-analysis, the authors concluded
either that remote monitoring was beneﬁcial or promising
because the studies included in these reviews showed
reductions in mortality.
Hospitalizations
There were more modest relative risk reductions from
remote monitoring for all cause compared with CHF-
related hospitalizations in the meta-analyses of RCTs,
see Figures 3 and Figure 4. For example, the greatest rela-
tive risk reduction of 0.72 (95% CI¼ 0.64–0.81) was for
CHF-related hospitalization12 compared with 0.92 (95%
CI¼ 0.85–0.99) for all-cause hospitalization.10
Cost
Two of the systematic reviews examined the cost-
eﬀectiveness of remote monitoring for heart failure.11,24
In the meta-analysis reported by Klersy et al.,11 remote
monitoring was found to reduce costs compared with
usual care with a gain in quality-adjusted life years
(QALY) of 0.06, indicating the superiority of this treat-
ment over usual care in terms of eﬀectiveness, cost and
therefore cost-eﬀectiveness. Another systematic review
reported cost reductions associated with remote monitor-
ing of 1.6–68.3%.24 The cost reductions resulted from
reduced hospitalizations and patient travel costs.
Self-care
One systematic review focused on the eﬀect of remote
monitoring on self-care.21 Most studies (n¼ 8) included
in this systematic review reported that remote monitoring
improved (P< 0.05) self-care behaviours such as fre-
quency of obtaining daily bodyweight, medication man-
agement, exercise adherence, and ﬂuid and salt
restriction.28,29 However, the review identiﬁed ﬁve studies
that showed no beneﬁt to self-care from remote monitor-
ing of heart failure.30,31
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Quality of life
No meta-analyses of the eﬀect of remote monitoring for
heart failure on quality of life measures were identiﬁed.
However, four systematic reviews reported that individual
studies had identiﬁed signiﬁcant (P< 0.05) improvements
in self-reported quality of life in heart failure patients
randomized to a remote monitoring intervention.9,10,14,26
Compliance
Compliance with the intervention was reported in ﬁve
reviews, see Table 4. Compliance was generally reported
to be high, ranging from 75–99%.10,13,17,22,25
Discussion
As far as we are aware, the present meta-review is the ﬁrst
to synthesise published systematic reviews of the eﬀective-
ness of remote monitoring in heart failure. Using the
AMSTAR tool to appraise the quality of the systematic
reviews, we were able to identify eight published system-
atic reviews that did not assess the scientiﬁc quality of the
included studies. Two further reviews were judged to be of
poor methodological quality, with total AMSTAR scores
below 8.
Seven reviews did, however, conform to the majority of
the AMSTAR criteria, were of high quality and can be
trusted to inform policy and practice decision making.
10.5 5.10
Structured telephone support
Structured telephone support and telemonitoring
Telemonitoring
Remote monitoring (invasive and non-invasive)
Inglis et al.
Inglis et al.
Study Risk Ratio
(95% CI)
Risk Ratio
(95% CI)
0.88 (0.76-1.01)
Polisena et al. 0.64 (0.48-0.85)
0.66 (0.54-0.81)
Clark et al. 0.80 (0.69-0.92)
Klersy et al. RCTs: 0.83 (0.73-0.95)
Cohort: 0.53 (0.29-0.96)
Clarke et al. 0.77 (0.61-0.85)
Figure 2. All-cause mortality results from meta-analyses.
10.5 5.10
Structured telephone support
Structured telephone support and telemonitoring
Telemonitoring
Remote monitoring (invasive and non-invasive)
Inglis et al.
Inglis et al.
Study Risk Ratio
(95% CI)
Risk Ratio
(95% CI)
0.92 (0.85-0.99)
Lee et al. 0.82 (0.68-0.92)
0.91 (0.84-0.99)
Clark et al. 0.95 (0.89-1.02)
Klersy et al. RCTs: 0.96 (0.90-1.03)
Cohort: 0.52 (0.28-0.96)
Clarke et al. 0.99 (0.88-1.11)
Figure 3. All-cause hospitalizations results from meta-analyses.
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These high quality reviews concluded that remote moni-
toring for heart failure improves mortality and quality of
life as well as reduces hospitalizations and, as a conse-
quence, healthcare costs. The reviews also suggest that
remote monitoring technologies are accepted as useful
by patients. Perhaps as a result, compliance was also
reported to be high. Based on these positive ﬁndings, fur-
ther eﬀorts should now be directed towards optimising
remote monitoring in heart failure in preparation for
more widespread implementation.
A high degree of heterogeneity was reported in many of
the meta-analyses included in the present review. In the
most recent Cochrane meta-analysis, heterogeneity of
interventions was managed by stratifying trials according
to the type of technology used, namely telemonitoring or
structured telephone support, with the former technique
appearing superior.10 An alternative method to overcome
the problem of heterogeneity could be to use a classiﬁca-
tion scheme for remote management of heart failure.32
This might facilitate more consistent interpretation of
data by incorporating both non-invasive and invasive
remote monitoring technologies. This is important
because the limitations of subjective sign and symptom
monitoring, as well as bodyweight-based monitoring of
ﬂuid status, indicate that invasive monitoring may be
more sensitive and speciﬁc for the early detection of clin-
ical deterioration.33 We found no systematic review which
had focused on invasive technologies for remote monitor-
ing of heart failure.
While the mechanisms by which remote monitoring
improves mortality and reduces the risk of hospitaliza-
tions for acute decompensated heart failure remains
uncertain, the results of our meta-review provide some
insight. As might be expected, remote monitoring is
more eﬀective in reducing CHF-related hospitalizations
than all-cause hospitalizations. Although it has been pro-
posed that better self-care improves early detection and
intervention, we could not ﬁnd substantial support for
this hypothesis.21 Further research is required to elucidate
why patients with heart failure generally experience better
clinical outcomes when remote monitoring technologies
are used.
10.5 5.10
Structured telephone support
Structured telephone support and telemonitoring
Telemonitoring
Remote monitoring (invasive and non-invasive)
Inglis et al.
Inglis et al.
Study Risk Ratio
(95% CI)
Risk Ratio
(95% CI)
0.77 (0.68-0.87)
0.79 (0.67-0.94)
Clark et al. 0.79 (0.69-0.89)
Klersy et al. RCTs: 0.72 (0.64-0.81)
Clarke et al. 0.73 (0.62-0.87)
Figure 4. Chronic heart failure-related hospitalizations results from meta-analyses.
Table 4. Compliance with the intervention.
Review
Reported
(Yes/No) Results
Chaudhry (2007) No
Cherofsky (2011) No
Clark (2007) No
Clarke (2011) Yes Six studies showed high levels
of compliance
Dang (2009) No
Giamouzis (2012) Yes 75–98.5%
Inglis (2010) Yes 80–97%
Klersy (2009) No
Klersy (2011) No
Kraai (2011) No
Lee (2010) No
Louis (2003) Yes ‘‘good acceptability ranging
from 80–90%’’ p584
Maric (2009) No
Martinez (2006) Yes One RCT showed that 88%
of the patients rated the
equipment as ‘very easy to
use’ p236
Polisena (2010) No
Radhakrishnan
(2012)
No
Seto (2008) No
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Anker et al. noted in their recent discussion paper that
a problem with meta-analyses of remote monitoring in
heart failure is that the trials which were included enrolled
patients who varied in clinical status, stability and degree
of previous treatment.32 We also found that no speciﬁc
determination of the eﬀect of remote monitoring in a
subset of heart failure patients could be derived from
the systematic reviews. Standardized reporting of popula-
tion characteristics in future research would be helpful.
The results of the higher quality meta-analyses included
in the present meta-review are in contrast with two recent
RCTs of remote monitoring for heart failure, neither of
which demonstrated an improvement in outcomes com-
pared with usual care.19,27 Data from these trials will
need to be incorporated into an updated meta-analysis.
However, two conclusions can be drawn from their results.
One trial (Tele-HF) used a voice-interactive system that
appears to have been disliked by many patients, since
14% of intervention patients did not use the technology
at all and only 55% used the technology at least three
times per week. In contrast, compliance was reported to
be 75-99% in the high quality meta-analyses.10,25 No per-
protocol analysis has been reported to investigate whether
the poor compliance aﬀected the results.
In the other trial (TIM-HF), the patients enrolled
demonstrated little variance in treatment, probably
because they were medically stable at the time of enrol-
ment.27 Sub-group analyses showed that the participants
who were hospitalized due to exacerbation of heart failure
prior to randomization derived the most beneﬁt from the
intervention.34 Thus, this trial provides evidence that it is
not the remote monitoring that produces improved clin-
ical outcomes but some kind of interaction involving the
patient and the health care provider. The complexity of
this interaction is not yet fully understood.
To our knowledge, only one other meta-review in tele-
medicine has used the AMSTAR instrument to appraise
the quality of systematic reviews.35 We consider that this
tool is appropriate, as it has good content validity and it
has been used previously to appraise the quality of meta-
analyses in heart failure disease management
programmes.7,36
It should be noted that only English language reviews
were included in the present study.We considered this to be
acceptable because English language reviews represent a
robust view of the available evidence base in health areas.37
In conclusion, our meta-review provides important
information for policy and practice decision-makers
regarding remote monitoring interventions for the man-
agement of patients with heart failure. By using the
AMSTAR tool for quality appraisal, we identiﬁed system-
atic reviews of high quality, which can be trusted to
inform decision-making. These high quality reviews sug-
gest that decision makers can expect the following beneﬁts
from remote monitoring of patients with heart failure: (1)
reductions in all-cause and heart failure-related hospital-
izations; (2) reductions in all-cause mortality; (3) reduc-
tions in healthcare costs; and (4) improved quality of life.
However, further research is required before widespread
implementation can be considered. The subset of the heart
failure population that derives the most beneﬁt from
intensive monitoring, the particular type or combination
of technology that provides the best collection, transmis-
sion and interpretation of data, and the optimum duration
that patients should be monitored, all need to be
identiﬁed.
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